333D Limited Posts $275K Quarterly Receipts, Annual Revenue Tops $970K
333D Limited reported a 12% increase in quarterly cash receipts from digital asset management contracts, maintaining steady cash flow despite slight operating cash usage. The company’s annual contract revenue surpassed $970,000, reflecting growing traction in healthcare digital services.
- 12.09% increase in quarterly cash receipts to $275,234
- Annual contract revenue exceeds $970,000
- Operating cash flow slightly negative at $85 used
- Quarterly expenditure totals approximately $275,342
- Payments to related parties amount to $12,042
Quarterly Revenue Growth
333D Limited (ASX – T3D) has released its quarterly cash flow report and activities update for the period ending 30 June 2025, highlighting a notable 12.09% increase in cash receipts from customers to $275,234. This growth is driven primarily by the company’s digital asset management contracts, which have gained momentum following the signing of two new healthcare provider agreements in mid-2024.
The company’s annual contract revenue now exceeds $970,000, underscoring the rising demand for its specialised services in digital capture, 3D content creation, and bespoke 3D printing solutions. This steady revenue stream reflects 333D’s successful positioning within the niche intersection of medical imaging and digital asset management.
Cash Flow and Expenditure Overview
Despite the revenue uptick, 333D reported a slight net operating cash outflow of $85 for the quarter, a reversal from the $23,012 cash inflow recorded in the previous quarter. Total expenditure for the quarter was approximately $275,342, allocated across product manufacturing and operating costs ($140,132), staff costs ($23,975), and administration and corporate expenses ($111,235).
The company’s cash position remains stable with cash and cash equivalents at $75,263 at quarter-end, closely mirroring the previous quarter’s balance. Notably, 333D made payments totaling $12,042 to related parties, primarily reimbursements to entities associated with directors John Conidi and Nigel Finch, in line with ASX disclosure requirements.
Strategic Position and Outlook
333D continues to capitalise on emerging opportunities in digital asset management and 3D printing, particularly within healthcare sectors where diagnostic imaging and bespoke digital content are increasingly vital. The company’s integration of artificial intelligence to encode data files into 3D printable formats positions it well for future growth as digital and physical interfaces converge.
While the report does not provide explicit forward guidance or detail on funding strategies, the absence of material post-quarter events and the maintenance of a stable cash position suggest operational continuity. Investors will be watching closely for how 333D leverages its growing contract base to improve cash flow and profitability in upcoming quarters.
Bottom Line?
333D’s steady revenue gains and stable cash position set the stage for cautious optimism as it navigates growth in a specialized digital niche.
Questions in the middle?
- How sustainable is the recent revenue growth from healthcare contracts?
- What are 333D’s plans to improve operating cash flow going forward?
- Could related party payments raise governance questions among investors?
